Norges Bank’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
MA
EDRH
NAMA
JSP
Norges Bank's PACB Position: Q3 2024 in Review
Norges Bank sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 1,213,637 shares — an estimated $1.66M sold.
Norges Bank first reported a position in PACB in Q4 2020 and held it in 15 quarters. The position peaked at $55M in Q1 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.
- Norges Bank reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
- Norges Bank sold 1,213,637 Pacific Biosciences shares in Q3 2024, an estimated $1.66M.
- Norges Bank first reported a position in Pacific Biosciences in Q4 2020 and held it in 15 quarters.
- Norges Bank's Pacific Biosciences position peaked at $55M in Q1 2021.
- 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.
Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.